Mezomax
San Francisco
About Mezomax
MezoMax enables faster bone fracture healing, improved osteoporosis treatment, and stronger bones in elderly patients with their novel calcium gluconate stereoisomer, which regulates calcium and mineral metabolism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Dec 2017)
- Website: mezomaxinc.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/mezomax-3200688 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.